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Abstract
One of the central goals of precision health is the understanding and interpretation
of high-dimensional biological data to identify genes and markers associated
with disease initiation, development and outcomes. Significant effort has been
committed to harness gene expression data as real-valued matrices for multiple
analyses while accounting for time-to-event modeling by including survival times.
Traditional biological analysis has focused separately on non-negative matrix
factorization (NMF) of the gene expression data matrix and survival regression with
Cox proportional hazards model. In this work, Cox proportional hazards regression
is integrated with NMF by imposing survival constraints. This is accomplished by
jointly optimizing the Frobenius norm and partial log likelihood for events such
as death or relapse. Simulation results based on synthetic data demonstrated the
superiority of the proposed methodology, when compared to other NMF algorithms,
in finding survival associated gene clusters. In addition, using breast cancer gene
expression data, the proposed technique can unravel critical clusters of cancer
genes. The discovered gene clusters reflect rich biological implications and can
help identify survival-related biomarkers. Towards the goal of precision health
and cancer treatments, the proposed algorithm can help understand and interpret
high-dimensional heterogeneous genomics data with accurate identification of
survival-associated gene clusters.
1 Introduction and Related Work
Identify genes and biomarkers associated with patient survival is of great interest to cancer researchers.
This has been facilitated by the advances in biotechnology such as next generation sequencing (NGS)
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as well as the availability of genomics, transcriptomics, proteomics, and other omics data, which
constitute an indispensable multi-omics source of biological information.
Survival analysis, also known as “time-to-event” analysis, aims to model patient lifespan and estimate
the time to an event of interest (especially a death event) given the observed data [1]. It is worth noting
that not all subjects of a given population will experience the event of interest (e.g., death) during the
study. Cases in which survival times exceeded study duration are labelled as “censored” [1]. Survival
analysis considers the lifetimes even when the subjects are not experiencing the event of interest (e.g.,
death). Though analyzing on gene expression matrix by Cox proportional hazards regression [2] is
the standard way of identifying survival associated genes, it does not aggregate high-dimensional
features nor account for the clustering property to identify gene clusters or pathways. Among the
numerous techniques used to discover feature contribution to a classification problem, non-negative
matrix factorization (NMF) have demonstrated the dual capability of dimensionality reduction and
clustering in latent dimension [3] which also reflects biological representation [4, 5] by introducing
non-negative constraint.
Non-negative matrix factorization (NMF), studied since 1999 [6], was initially developed for face
recognition [7, 8, 9, 10], but has since been applied to biological analysis including gene clustering
[11, 12, 13, 14, 4] and provide new insights about complex latent relationships in high-dimensional
biological data [5]. It decomposes a non-negative matrix X into two low-rank matrices: a basis
matrixW representing features, and a coefficient matrixH representing samples, provides a well-
established geometrical and topological perspective to understand the feature space by visualizing the
basis matrix. Different from other matrix factorization methods, the imposed non-negative property
onW andH can lead to interpretable results [6].
Applying NMF in biological studies such as unveiling gene interactions and clusters have been
exploited since last decade. Liu et al. [15] compared PCA with NMF to reduce the dimension of
microarray data and showed the superiority of NMF. Zheng et al. [16] used NMF technique to identify
tumor types. Wang et al. [17] and Gao et al. [18] performed cancer clustering with NMF algorithms.
Using NMF to perform gene expression clustering can be found in [19, 20, 21, 22, 23, 11, 12]. For
example, Wang et al. [23] proposed LS-NMF to link functionally related genes. More recently, Zhu
et al. [13] suggested that NMF is well-suited to analyze heterogeneous single-cell RNA-Seq data.
Jiang et al. [14] used NMF to unravel disease-related genes. Jia et al. [24] developed discriminant
NMF to rank genes. Lai et al. [4] performed survival prediction after NMF-based pre-selection of
genes.
Though there is evidence that NMF has an inherent clustering property [3], fully utilizing the survival
data along with the given gene expression matrix and effectively integrating hazards provided by
survival information in its update rule has not be systematically study. To address this gap, we aim
to find an ideal solution to the NMF along with the associated survival data simultaneously. The
derived solution successfully demonstrated the power of retrieving survival associated clusters in
both synthetic data and human cancer expressions. As a success endeavor towards the central goal of
precision health and cancer treatments, the proposed algorithm CoxNMF can help understand and
interpret high-dimensional biological data, as well as unveiling critical gene clusters that associated
with survival.
2 Formulation of CoxNMF
In this section, we first introduce the proposed algorithm named “CoxNMF”, especially how the
objective function was constructed as well as the solution. Then, we based on the developed
algorithms, performed experiments on simulated time to event data to show its superiority. After the
simulation study, we performed the analysis to real human cancer data and aimed to discover the
clusters of genes which may play important roles to survival.
2.1 Input and Output Data
In this section, we assume the input gene expression dataX with shape P by N to be non-negative,
real-valued 2-dimensional matrix, which may contains several zero-valued entries. The rows indicate
P features/genes, and the columns indicate N samples/patients. The output generated by CoxNMF
has two parts: a low-rank K by N coefficient matrixH which learned from NMF and Cox propor-
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tional hazards regression, and a low-rank P by K basis matrixW , associated withH that minimizes
the Frobenius norm‖X −WH‖F .
2.2 Objective Function
Given the target non-negative matrix X , two initialized non-negative matrices W and H , the
objective function of CoxNMF is
Minimize ‖X −WH‖2F − α`H,β(C, Y ) + ξ‖β‖1 (1)
subject to Xi,j ≥ 0 ∀i ∈ [0, P ], j ∈ [0, N ], Wi,j ≥ 0 ∀i ∈ [0, P ], j ∈ [0,K], and Hi,j ≥ 0 ∀i ∈
[0,K], j ∈ [0, N ]. Where α, ξ ≥ 0 are two positive weights,‖·‖F is the Frobenius norm, also known
as Euclidean distance [25], C stand for the death events, Y stand for survival times. `H,β(C, Y ) is
the log partial likelihood [2]:
`H,β(C, Y ) =
∑
i:Ci=1
βTHi − log
 ∑
j:Yj≥Yi
exp(βTHj)

 . (2)
The log partial likelihood `H,β(C, Y ) is derived based on the partial likelihood Li(β,H) of the
death event to be observed occurring for patient i at time Yi:
Li(β,H) = λ(Yi|Hi)∑
j:Yj≥Yi λ(Yi|Hj)
=
λ0(Yi)exp(βTHi)∑
j:Yj≥Yi λ0(Yi)exp(β
THj)
=
exp(βTHi)∑
j:Yj≥Yi exp(β
THj)
,
(3)
where λ is the hazard function, and β stand for the covariates associated to the log partial likelihood
function.
2.3 CoxNMF Update Rule
Given the target non-negative matrix X , two initialized non-negative matrices W and H , an
initialized parameter β for Cox proportional hazards model, and a certain number of iterations M ,
we propose the CoxNMF alternately iterative update algorithm
W
(iter+1)
i,j ←W (iter)i,j 
XH
(iter)
i,j
T
W
(iter)
i,j H
(iter)
i,j H
(iter)
i,j
T
, (4)
β(iter+1) ← β(iter) + γβ
∂`H(iter),β(C, Y )
∂β
+ ξ
‖β‖1
∂β
= β(iter) + γβ
∑
i:Ci=1
(
Hi −
∑
j:Yj≥Yi exp(β
THj)Hj∑
j:Yj≥Yi exp(β
THj)
)
+ ξ
‖β‖1
∂β
,
(5)
H
(iter+1)
i,j ←
H(iter)i,j + α2 max
{
0,
∂`H(iter),β(C, Y )
∂H(iter)
} W (iter+1)i,j TX
W
(iter+1)
i,j
T
W
(iter+1)
i,j H
(iter)
i,j
.
(6)
Where
∂`H,β(C, Y )
∂H
=

∂`H,β(C,Y )
∂H1,1
∂`H,β(C,Y )
∂H1,2
· · · ∂`H,β(C,Y )∂H1,n
∂`H,β(C,Y )
∂H2,1
∂`H,β(C,Y )
∂H2,2
· · · ∂`H,β(C,Y )∂H2,n
...
...
. . .
...
∂`H,β(C,Y )
∂Hk,1
∂`H,β(C,Y )
∂Hk,2
· · · ∂`H,β(C,Y )∂Hk,n

=
(C1β − n∑
s=1
Cs
1(Y1≥Ys)βexp(β
TH1)∑
j:Yj≥Ys exp(β
THj)
)
· · ·
(
Cnβ −
n∑
s=1
Cs
1(Yn≥Ys)βexp(β
THn)∑
j:Yj≥Ys exp(β
THj)
) ,
(7)
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1(Yn≥Ys) =
{
1 if Yn ≥ Ys
0 otherwise
is the indicator function. The Wˆ and Hˆ are returned where the
algorithm achieved maximum C-Index during the optimization. Newton-Raphson [26] as maximum
partial likelihood estimator (MPLE) [27] with lifelines python package [28] was used for updating
Equation 5, and γβ is the step size with regards to the update. Pseudo code is also presented below.
Algorithm 1: COXNMF
Input :X , K, Y , C, α, M .
Output :W ,H , β, and CI .
Initialization :InitializeW (0),H(0), β(0), empty list CI .
for iter = 0 : M − 1 do
W (iter+1) ←W (iter)  XH(iter)T
W (iter)H(iter)H(iter)T
β(iter+1) ← β(iter) + γβ
∂`
H(iter),β
(C,Y )
∂β + ξ
‖β‖1
∂β
H(iter+1) ←
(
H(iter) + α2 max
{
0,
∂`
H(iter),β
(C,Y )
∂H(iter)
})
 W (iter+1)TX
W (iter+1)TW (iter+1)H(iter)
CI[iter + 1] = CONCORDANCEINDEX(β(iter+1)
T
H(iter+1), Y, C)
end
imax = argmax(iter) CI
W = W (imax)
H = H(imax)
β = β(imax)
CI = CI[imax]
returnW ,H, β, CI
2.4 Evaluation Metrics
Silhouette Score for Determining Optimal Number of Latent DimensionK
The silhouette score, or mean silhouette coefficient, measures the consistency within clusters of data.
The score describes how well each element has been classified [29]. In this study, Euclidean distance
was adopted as distance metric. We used silhouette score to determine the optimal values of Kˆ as the
estimations to K among experiments.
Quantitative Measurements of Optimization Results and Label Accuracy
To tune the hyper-parameters as well as evaluating the performance of optimization results along
with survival information, the concordance index (C-Index) was adopted. It is a generalization
of the area under the ROC curve (AUC) which introduces the censorship information. It as-
sesses the model discrimination power of the ability to correctly provide a reliable ranking of
the survival times based on the individual risk scores and can be computed with the formula
C-Index =
∑
i,j 1(Yj<Yi)·1(rj>ri)·Cj∑
i,j 1(Yj<Yi)·Cj
, where rj is the risk score of a subject j. 1(Yj<Yi) is the
indicator function: 1(Yj<Yi) =
{
1 if Yj < Yi
0 otherwise
. Similar to the AUC, C-Index = 1 corresponds to
the best model prediction, and C-Index = 0.5 represents a random prediction.
To quantify whether models can identify the survival-associated gene clusters correctly, we adopted
four measurements to evaluate the results, namely, accuracy, F-1 score, precision, and recall. The F-1
score is formulated as F-1 = 2(precision× recall)/(precision + recall).
3 Experiments
Our method was first validated on three different sizes of synthetic data to show its efficacy, and
then applied on a human breast cancer dataset. In simulation study, CoxNMF was compared with
two baseline NMF with updating rules Coordinate Descent (CD) solver and Mutiplicative Update
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(MU) solver. In addition, we also compared to supervised non-negative matrix factorization (SNMF)
[30] which imposed linear regression into the NMF optimization process. In SNMF, survival times t
are regressed. Unlike CoxNMF which simultaneously minimize the Frobenius norm and maximize
the partial log likelihood, NMF (CD), NMF (MU), and SNMF performed Cox proportional hazards
regression on Hˆ after the NMF updating finished. All algorithms have M = 200 iterations for NMF
and Cox proportional hazards regression steps. All methods imposed L1 norm on β with weight
ξ = 0.1. We tuned α = vP , β =
v
K , γ =
v
N×K , v ∈ {0.001, 0.01, 0.1} for SNMF according to [30]
and α ∈ {0.1, 0.2, 0.5} for CoxNMF among all experiments, where P,N,K stands for number of
features, patients, and low-rank dimensions, respectively. The results where the C-Index achieved
highest during the optimization will be used.
3.1 Simulation Study with Synthetic Data
In this simulation, we consider the cohort contains N = 100 patients. The survival time ti of
patient i were constructed in ascending order follows exponential distribution λe−λt with λ = 100,
i ∈ {1, 2, · · · , N}. All patients will have a complete event (Ci = 1) in this ideal situation. For
the basis matrixW , we assumed it behaved non-negative with exponential distribution [2]. For the
coefficient matrixH , we assumed it behaved non-negative with uniform distribution except several
dimensions which carried survival information.
With K number of latent gene clusters each consists of 50 genes, we have the ground truth basis
matrixW in block diagonal with dimension P by K and the ground truth coefficient matrixH with
dimension K by 100. In this case, P = 50 ·K. We denoteW (k) as the kth block consists of 50 genes
in one cluster. Each element w ∈W (k) follows i.i.d. exponential distribution ae−aw with a = 1.
For H , each row k ∈ {1, · · · ,K} of Hk,· follows i.i.d. uniform distribution U(0, 1) except the
first and last rows. The first/last rows were artificially created to be perfectly concord/discord with
survival time. Specifically, the value of first rowHk=0,i was constructed from 0.5 to 0.698 with step
size = 0.02 (C-Index = 0). The value of last row Hk=K,i was constructed from 0.698 to 0.5 with
step size = −0.02 (C-Index = 1). This simulation setting hypothesized that only first/last row carried
survival information which lead to better/worse prognosis (longer/shorter survival time). Then the
corresponding gene clusters for the first blockW (1) reflect those genes were associated with better
prognosis and vice versa forW (K). With this setting, our goal is to unravel the gene clustersW (1)
associated with better prognosis andW (K) associated with worse prognosis.
ε = 0.00 ε = 0.05 ε = 0.10
Kˆ = 5 Kˆ = 7 Kˆ = 9 Kˆ = 5 Kˆ = 7 Kˆ = 9 Kˆ = 5 Kˆ = 7 Kˆ = 9
K
=
7 NMF (CD) 0.8613±0.03 1.0000±0.00 0.7112±0.02 0.7148±0.01 0.7603±0.02 0.6770±0.04 0.6332±0.02 0.6267±0.04 0.5582±0.03
NMF (MU) 0.8511±0.02 0.9996±0.00 0.9008±0.06 0.7053±0.02 0.7400±0.04 0.7209±0.02 0.6345±0.01 0.6215±0.03 0.5769±0.03
SNMF 0.8461±0.02 1.0000±0.00 0.7557±0.06 0.6962±0.01 0.7540±0.02 0.6962±0.02 0.6172±0.01 0.6347±0.02 0.5644±0.03
CoxNMF 0.8383±0.01 0.9974±0.00 0.8879±0.04 0.6864±0.01 0.7320±0.04 0.6538±0.03 0.5802±0.04 0.6197±0.03 0.5590±0.03
Kˆ = 7 Kˆ = 9 Kˆ = 11 Kˆ = 7 Kˆ = 9 Kˆ = 11 Kˆ = 7 Kˆ = 9 Kˆ = 11
K
=
9 NMF (CD) 0.8828±0.02 1.0000±0.00 0.8042±0.04 0.7175±0.03 0.7452±0.02 0.6944±0.02 0.6139±0.03 0.6031±0.02 0.5625±0.03
NMF (MU) 0.8774±0.02 0.9994±0.00 0.9250±0.03 0.7042±0.01 0.7223±0.02 0.7247±0.01 0.6007±0.02 0.6133±0.02 0.5908±0.01
SNMF 0.8835±0.01 1.0000±0.00 0.7992±0.07 0.7131±0.02 0.7549±0.02 0.7148±0.02 0.6042±0.02 0.6322±0.02 0.5749±0.02
CoxNMF 0.8704±0.02 0.9960±0.00 0.9451±0.01 0.6807±0.02 0.7250±0.03 0.6773±0.02 0.5778±0.01 0.6008±0.03 0.5716±0.02
Kˆ = 9 Kˆ = 11 Kˆ = 13 Kˆ = 9 Kˆ = 11 Kˆ = 13 Kˆ = 9 Kˆ = 11 Kˆ = 13
K
=
11
NMF (CD) 0.8960±0.01 1.0000±0.00 0.8173±0.01 0.6922±0.02 0.7295±0.04 0.6832±0.04 0.5781±0.03 0.5903±0.04 0.5483±0.05
NMF (MU) 0.8834±0.01 0.9994±0.00 0.9257±0.01 0.6942±0.02 0.7340±0.03 0.7224±0.03 0.5892±0.02 0.6092±0.03 0.5814±0.03
SNMF 0.8898±0.01 1.0000±0.00 0.7874±0.02 0.6987±0.02 0.7455±0.02 0.7190±0.02 0.5836±0.03 0.6165±0.04 0.5714±0.04
CoxNMF 0.9008±0.02 0.9963±0.00 0.9308±0.03 0.6727±0.02 0.7124±0.02 0.6840±0.02 0.5743±0.03 0.6039±0.03 0.5638±0.02
Table 1: Silhouette score for different combinations of ε, K and Kˆ reported by four models in the
simulation. Performances reported in mean ± standard deviation. Highest mean values among Kˆ
were styled in bold text.
The ground truth data matrix X was then constructed as X = WH + E. The matrix E sug-
gests an artificial noise introduced into the system followed exponential distribution εe−εw with
ε ∈ {0, 0.05, 0.1}. As in reality K remains unknown, the first step is required to determine the
optimal hyper-parameter Kˆ according to the silhouette score. We performed experiments with all
combinations of K ∈ {7, 9, 11} and searching Kˆ ∈ {5, 7, 9, 11, 13}. All experiments ran 5 times
each with different random seeds for the initialization and optimizations. From Table 1 we found
almost all algorithms can found the optimal Kˆ = K based on highest silhouette score especially
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the proposed CoxNMF. This step helped us to determine number of the latent dimension K in the
simulation study.
After row normalization on the resulting basis matrix W¯p = Wˆp/
∥∥∥Wˆp∥∥∥ for each row p, we
applied the Cox proportional hazards regression parameter weighted on the normalized basis matrix:
W˜p = β
T  W¯p (i.e., the β parameter will multiply each row p of W¯ element-wisely), and sort the
columns and rows of W˜ andH , as well as β according to β in ascending order, respectively. Note that
the elements of W˜ can be negative. In this case, a positive value in W˜ suggests an association with
worse prognosis and vise versa. Then a hierarchical agglomerative clustering measured in Euclidean
distance with Ward linkage [31] was performed on W˜ to determine the optimal Kˆ according to the
highest silhouette score and clusters Lj , j ∈ {1, 2, · · · , Kˆ}.
ε = 0.00 ε = 0.05 ε = 0.10
Kˆ = 7 Kˆ = 9 Kˆ = 11 Kˆ = 7 Kˆ = 9 Kˆ = 11 Kˆ = 7 Kˆ = 9 Kˆ = 11
C
-I
nd
ex NMF (CD) 0.9931±0.01 0.9897±0.01 0.9794±0.01 0.9823±0.00 0.9734±0.01 0.9816±0.00 0.9639±0.00 0.9565±0.01 0.9610±0.01
NMF (MU) 0.8777±0.10 0.7890±0.08 0.7616±0.13 0.8906±0.07 0.8049±0.08 0.7520±0.13 0.8907±0.06 0.7992±0.07 0.7220±0.11
SNMF 0.9986±0.00 0.9964±0.00 0.9932±0.00 0.9844±0.00 0.9838±0.00 0.9843±0.00 0.9666±0.00 0.9640±0.00 0.9682±0.00
CoxNMF 0.9998±0.00 0.9997±0.00 0.9983±0.00 0.9999±0.00 0.9977±0.00 0.9993±0.00 0.9983±0.00 0.9984±0.00 0.9987±0.00
A
cc
ur
ac
y NMF (CD) 0.8571±0.00 0.8444±0.06 0.8727±0.05 0.7989±0.08 0.8291±0.05 0.9049±0.05 0.8311±0.05 0.8267±0.04 0.8953±0.06
NMF (MU) 0.7714±0.08 0.8222±0.06 0.8545±0.05 0.7714±0.11 0.7944±0.07 0.8375±0.07 0.7734±0.11 0.8087±0.06 0.8262±0.00
SNMF 0.8857±0.06 0.8889±0.00 0.9273±0.04 0.8580±0.13 0.8060±0.13 0.9256±0.03 0.9466±0.02 0.9067±0.08 0.8849±0.03
CoxNMF 0.9146±0.09 0.9562±0.06 0.9293±0.05 0.9489±0.06 0.9496±0.05 0.9640±0.03 0.9437±0.05 0.8933±0.05 0.9444±0.04
F-
1
sc
or
e NMF (CD) 0.7083±0.00 0.6062±0.15 0.6150±0.15 0.6674±0.05 0.5516±0.15 0.6966±0.17 0.6374±0.12 0.5307±0.12 0.6656±0.20
NMF (MU) 0.5333±0.16 0.5500±0.15 0.5600±0.15 0.5255±0.24 0.5549±0.12 0.5485±0.14 0.5263±0.24 0.5628±0.12 0.4524±0.00
SNMF 0.7667±0.13 0.7188±0.00 0.7800±0.12 0.7861±0.17 0.6563±0.20 0.7804±0.11 0.8947±0.03 0.7626±0.20 0.6356±0.10
CoxNMF 0.7941±0.23 0.8439±0.23 0.7111±0.23 0.8922±0.12 0.8677±0.14 0.8810±0.10 0.8790±0.10 0.7415±0.10 0.8069±0.13
Pr
ec
is
io
n NMF (CD) 0.7083±0.00 0.6062±0.15 0.6150±0.15 0.6676±0.04 0.5504±0.15 0.7022±0.17 0.6432±0.13 0.5296±0.12 0.6693±0.21
NMF (MU) 0.5333±0.16 0.5500±0.15 0.5600±0.15 0.5207±0.23 0.5539±0.12 0.5525±0.14 0.5241±0.23 0.5605±0.11 0.4504±0.00
SNMF 0.7667±0.13 0.7188±0.00 0.7800±0.12 0.7833±0.18 0.6608±0.19 0.7754±0.11 0.8907±0.05 0.7744±0.21 0.6424±0.11
CoxNMF 0.8207±0.25 0.9329±0.12 0.8246±0.23 0.9168±0.13 0.8780±0.14 0.9254±0.11 0.9003±0.11 0.7537±0.13 0.8542±0.14
R
ec
al
l NMF (CD) 0.7083±0.00 0.6062±0.15 0.6150±0.15 0.7110±0.04 0.5530±0.15 0.6930±0.18 0.6348±0.12 0.5324±0.12 0.6625±0.19
NMF (MU) 0.5333±0.16 0.5500±0.15 0.5600±0.15 0.5308±0.25 0.5773±0.13 0.5452±0.15 0.5287±0.24 0.5765±0.12 0.4544±0.00
SNMF 0.7667±0.13 0.7188±0.00 0.7800±0.12 0.8263±0.14 0.7220±0.19 0.7899±0.11 0.9030±0.01 0.7532±0.19 0.6298±0.10
CoxNMF 0.7843±0.22 0.8468±0.22 0.7010±0.21 0.8727±0.11 0.8588±0.14 0.8479±0.09 0.8630±0.10 0.7396±0.08 0.7741±0.12
Table 2: Concordance index (C-Index), accuracy, F-1 score, precision, and recall for different
combinations of ε and K = Kˆ reported with mean ± standard deviation by four models in the
simulation. Highest mean values among an evaluation at certain Kˆ were styled in bold text.
To find the survival associated gene clusters, we focused on the smallest β1 and largest βK
associated with W˜ , the estimated labels yˆ− = argminLj
1∑
j Lj=1
∑
j W˜Lj=1,1 and yˆ+ =
argmaxLj
1∑
j Lj=1
∑
j W˜Lj=1,K are determined by the cluster Lj with highest absolute mean
value on the 1st and K th columns, respectively. The true labels y− (or y+) for better (or worse)
prognosis genes equals to 1 at where the genes reside atW (1) (or atW (K)). We concatenated y−
and y+ as y, and concatenated yˆ− and yˆ+ as yˆ. Then we compared our true labels y and estimated
labels yˆ via four metrics: accuracy, F-1 score, precision, and recall to quantify the performances of
finding survival-associated gene clusters.
From Table 2 we observed that the proposed CoxNMF achieved highest C-Index as well as accuracy,
F-1 score, precision, and recall at most cases among all experiments. One of the experimental result
with Kˆ = 7 was presented in Figure 1 where CoxNMF achieved highest concordance index = 0.9998
with accuracy = 0.9671, F-1 score = 0.9284, precision = 0.9610, and recall = 0.9017.
3.2 Human Cancer Gene Expressions
To improve precision health and cancer treatments, we are particularly interested in discovering novel
gene clusters behind the gene expression matrix and the corresponding survival information. The
goal of discovering latent cancer gene interaction groups can help biologist reveal gene functions,
setup biological experiments, or help develop drugs based on targeted genes.
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Figure 1: A result with K = Kˆ = 7, ε = 0.05. (A) Ground truth clusters C1, C2, · · · , C7. (B)
ground truth W , note that W (1) associated with better prognosis (longer survival time), W (7)
associated with worse prognosis. (C) Hierarchical agglomerative clustering results based on W˜ with
Kˆ number of clusters highlighted by most distinct colors. (D) W˜ , row orders are permuted according
to the hierarchical clustering result. Cluster with highest mean value on the smallest β1 and cluster
with highest mean value on the largest β7 were highlighted with blue rectangle and red rectangle. (E)
Ground truth labels in plot A with row permutation according to the hierarchical clustering result. (F)
Survival time t. (G) Hˆ . Columns of W˜ and rows of Hˆ were sorted in ascending order of β.
As an example, breast invasive carcinoma (BRCA), one of the most critical cancer for female
patients, was involved in the study. Gene expression data (mRNA-seq) was downloaded from Broad
GDAC Firehose (https://gdac.broadinstitute.org/). Since gene expressions remained a
considerable amount of noises, 20% of genes with lowest expression mean and 20% of genes with
lowest expression variance were excluded according to [32]. All expressions were normalized in
log2 scale X = log2(X + 1) according to [32]. We ended up with 13,140 genes and 1,079 female
patients for BRCA. To save the computational time, we searched Kˆ from 20 to 200 with step size
= 10 by using the NMF coordinate descend algorithm. We found Kˆ = 20 for BRCA yield highest
silhouette scores. The experiment adopted ξ = 1× 103 for L1 regularization of Cox proportional
hazards regression in Equation 5 and α = 5 × 104 for CoxNMF in Equation 6. The optimization
results W˜ and Hˆ for BRCA are reported in Figure 2. By performing gene ontology (GO) analysis
with ToppGene analysis suite [33], certain GO biological process terms or chromosome location
(cytoband) were exploited. The measurement of the enrichment results was based on P-value using
the hypergeometric distribution [34]. A smaller P-value indicates a more significant association of
gene cluster to the particular GO terms. Top 3 GO terms with smallest P-value were reported for each
cluster.
For breast invasive carcinoma (BRCA), a hierarchical clustering was performed (Figure 2AB)
according to the derived W˜ (Figure 2C). We also presented the corresponding Hˆ (Figure 2D) sorted
by survival time (Figure 2E) in ascending order. To show the differences between original gene
expression matrixX and low-rank reorganized W˜ , a t-SNE plot forX with perplexity = 30 was
reported in Figure 2F. A cluster spreads over the t-SNE plot in Figure 2F suggests the effectiveness
of low-rank reorganization in helping find survival associated clusters rather than in original data
X . In Table 3, gene cluster C18 was identified to be associated with better prognosis, while C4
behaved in contrast. We found the most significant terms are from GO biological process for C18
associated with better prognosis, while the most significant terms are from chromosome location
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(cytoband) for C4 associated with worse prognosis. From the results, we verified that extracellular
matrix organization, a descendant of extracellular structure organization, is associated with better
prognosis, which is increasingly recognized as an important regulator in breast cancer [35]. We also
found that the animal organ morphogenesis is also highly overlapped with gene cluster C18. For
gene cluster C4, we found a strong association with chromosome 1q21.3, which echos the existed
evidence that 1q21.3 amplified breast tumors [36]. These findings demonstrated that CoxNMF can
unravel survival associated gene clusters precisely.
Gene cluster C18 associated with better survival prognosis
Rank Term Description Input genes Genes in GO term Genes overlapped P-value
1 GO:0030198 Extracellular matrix organization 474 399 93 4.65× 10−66
2 GO:0043062 Extracellular structure organization 474 511 96 5.24× 10−59
3 GO:0009887 Animal organ morphogenesis 474 1241 113 4.88× 10−37
Gene cluster C4 associated with worse survival prognosis
Rank Term Description Input genes Genes in GO term Genes overlapped P-value
1 1q21 Chromosome 1q21 450 93 28 1.37× 10−30
2 1q21.3 Chromosome 1q21.3 450 118 26 1.34× 10−24
3 1q22 Chromosome 1q22 450 57 18 1.53× 10−20
Table 3: Gene ontology enrichment analysis results for breast invasive carcinoma (BRCA).
Figure 2: Experimental results on breast invasive carcinoma (BRCA). (A) hierarchical agglomerative
clustering with Kˆ = 20 labels (B) according to the derived W˜ sorted by β in rows (C). (D) The
corresponding Hˆ sorted by survival time (E) in columns and sorted by β in rows. Lowest and highest
β were highlighted on the right side. (E) Survival time, patients who had death events are highlighted
with pink vertical lines. (F) t-SNE plot ofX with perplexity = 30. Cluster labels are highlighted at
the geometrical center in the plot. Points in blue and red colors indicate the true location onX with
respect to cluster C18 and C4, respectively.
4 Conclusion
In this paper, a novel algorithm CoxNMF was proposed by integrating non-negative matrix factor-
ization and Cox proportional hazards regression. We carried out the objective function and update
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rules for CoxNMF. To the best of our knowledge, this is the first work that performed non-negative
matrix factorization and clustering driven by survival regression, which is accomplished by jointly
optimization of the Frobenius norm and partial log likelihood. The proposed algorithm successfully
demonstrated its superiority of identifying survival-associated gene clusters among other non-negative
matrix factorization algorithms in three different sizes of synthetic data. The experiment conducted
on human breast invasive carcinoma cancer helped unravel latent gene clusters which reflect rich
biological interpretations, achieved the goal of understanding and interpretation of high-dimensional
biological data in precision health.
Broader Impact
As a success endeavor towards the central goal of precision health and cancer treatments, this paper
proposed the algorithm CoxNMF for understanding and interpretation of high-dimensional biological
data. The proposed algorithm can help researchers discover critical genes associated with survival.
When the important gene clusters are identified with the association to the survival, it is recommended
to conduct further wet-lab experiments such as cancer cell line in order to validate the discovered
biomarkers/genes.
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